Indian Immunologicals MD recognised for his leadership in vaccine research, manufacturing and strengthening India’s human and animal healthcare sectors
Hyderabad, October 29, 2026: Dr K. Anand Kumar, Managing Director of Indian Immunologicals Limited (IIL), has been conferred with the prestigious FABA Lifetime Achievement Award by the Federation of Asian Biotech Associations (FABA), in recognition of his significant contributions to biotechnology, vaccine research, development and manufacturing, and the advancement of human and animal healthcare in India.
The award recognises Dr Kumar’s distinguished professional journey, leadership and contributions towards strengthening India’s vaccine ecosystem and making quality vaccines accessible and affordable. His work in scientific research, innovation and public health has contributed to advancing India’s capabilities in biotechnology and biologicals.
The FABA Lifetime Achievement Award has a distinguished legacy of recognising eminent personalities who have made significant contributions to biotechnology and life sciences. Previous recipients include Dr Cyrus Poonawalla, Chairman and Managing Director of Serum Institute of India; Dr Patrick Vallance, former President of R&D at GlaxoSmithKline, UK; Dr Balram Bhargava, former Director General of the Indian Council of Medical Research (ICMR); and Dr Soumya Swaminathan, former Chief Scientist of the World Health Organization (WHO).
The recognition places Dr Kumar among distinguished leaders who have contributed to the growth of the biotechnology and life sciences sectors.
Strengthening India’s Vaccine and Biotechnology Ecosystem
Under Dr Kumar’s leadership, Indian Immunologicals Limited has continued to strengthen its position as a vaccine manufacturer, contributing to India’s self-reliance in vaccines for human and animal healthcare.
The organisation has been involved in developing and manufacturing vaccines addressing critical public health requirements, disease prevention and animal healthcare. Its contributions also support broader priorities related to livestock health and food security.
Dr Anand Kumar Acknowledges Collective Efforts Behind the Recognition
Commenting on receiving the award, Dr K. Anand Kumar, Managing Director, Indian Immunologicals Limited, said, “I am deeply honoured to receive this Lifetime Achievement Award from FABA. I consider this recognition a tribute to the collective efforts of the scientific community, researchers, healthcare professionals and the entire team at Indian Immunologicals Limited.
“India’s biotechnology sector has made remarkable progress, and I believe that continued investment in research, innovation and indigenous vaccine development will be instrumental in addressing emerging health challenges and strengthening our nation’s preparedness for the future. This recognition further inspires us to remain committed to our mission of safeguarding human and animal health.”
FABA Recognises Contributions to Biotechnology and Life Sciences
The Federation of Asian Biotech Associations (FABA) plays an important role in promoting biotechnology innovation, encouraging collaboration and recognising individuals and institutions that have made significant contributions to the biotechnology ecosystem across Asia and beyond.
Dr Kumar’s recognition highlights his contributions to scientific innovation, institution building and India’s vaccine development capabilities. It also reflects Indian Immunologicals Limited’s continued focus on developing and providing quality, affordable vaccines for human and animal healthcare.